Dermatology
Latest News
Study Finds Variations in Pediatric Dermatologists Who Accept Medicaid
More research is needed on “the impact on health outcomes when specialty services are unavailable,” the authors wrote.
Latest News
Dermatofibrosarcoma Protuberans More Common In Black Patients, Analysis Finds
Researchers used the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) registry from 2000 through 2018 to provide a...
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Latest News
Study Addresses Litigation Related to Cutaneous Energy-based Based Device Treatments
Complications from energy-based devices included burns, scarring, and pigmentation changes.
Latest News
FDA Approves Topical Anticholinergic for Axillary Hyperhidrosis
Approval was based on results from two phase 3 studies that enrolled 710 patients with primary axillary hyperhidrosis.
Latest News
Study Finds Major CV Event Risk in Patients With AD Similar to Controls
An unexpected result was that among patients with moderate to severe AD, the risk for MACE was not significantly different from that of non-AD...
Latest News
Atopic Dermatitis: Study Compares Prevalence by Gender, Age, and Ethnic Background
“Results are important for us to consider targeted strategies to address AD burden,” said Raj Chovatiya, MD, PhD....
Latest News
Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years
No treatment-related interruptions, discontinuations, or serious adverse events were observed between baseline and week 52.
Latest News
Pediatric Atopic Dermatitis: Study Suggests Treatment May Impact Atopic March
Over 3 years, the dupilumab-treated cohort had a significantly lower cumulative incidence of atopic march progression.
Latest News
Meta-Analysis Finds Combination Cream Plus Tranexamic Acid Effective for Melasma
Tranexamic acid, an antifibrinolytic drug, has shown promise in recent studies, but its optimal use, either alone or as an adjunct to TCC, remains...
Latest News
OTC Supplement Linked to Hyperpigmentation
CHICAGO —“Many of our patients think kratom is a safe, herbal supplement” but often don’t know it can have several...